Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
Delayed Nasdaq  -  04:00 2022-12-07 pm EST
179.00 USD   +3.15%
04:57pModerna Appoints Brad Miller Chief Information Officer
MT
12/06EU regulator backs bivalent COVID shots for primary vaccination
RE
12/06EU regulator backs bivalent COVID vaccines for primary vaccination
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Argus Adjusts Moderna's Price Target to $150 From $180, Reiterates Buy Rating

09/14/2022 | 08:09am EST


ę MT Newswires 2022
All news about MODERNA, INC.
04:57pModerna Appoints Brad Miller Chief Information Officer
MT
12/06EU regulator backs bivalent COVID shots for primary vaccination
RE
12/06EU regulator backs bivalent COVID vaccines for primary vaccination
RE
12/06Global markets live: Vodafone, PepsiCo, Microsoft, Implenia, Pfizer...
MS
12/06It just doesn't add up
MS
12/06Britain's health regulator backs COVID vaccine for infants from six months
RE
12/05Pfizer, BioNTech Ask US Court to Junk Moderna's COVID-19 Vaccine Patent Infringement La..
MT
12/05Pfizer, BioNTech countersue Moderna over COVID-19 vaccine patents
RE
12/05Pfizer, BioNTech countersue Moderna over COVID-19 vaccine patents
RE
12/05Pfizer applies for FDA authorization for Omicron-retooled vaccine booster in kids under..
RE
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2022 19 089 M - -
Net income 2022 8 897 M - -
Net cash 2022 12 022 M - -
P/E ratio 2022 8,30x
Yield 2022 -
Capitalization 68 768 M 68 768 M -
EV / Sales 2022 2,97x
EV / Sales 2023 6,27x
Nbr of Employees 2 700
Free-Float 90,3%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Last Close Price 179,00 $
Average target price 211,25 $
Spread / Average Target 18,0%
EPS Revisions
Managers and Directors
StÚphane Bancel Chief Executive Officer & Director
Stephen Hoge President
James M. Mock Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.-31.67%66 671
IQVIA HOLDINGS INC.-25.61%38 981
LONZA GROUP AG-36.87%37 974
ALNYLAM PHARMACEUTICALS, INC.33.39%27 022
SEAGEN INC.-23.73%21 892
CELLTRION, INC.-11.87%17 962